Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists)

Autor: Wong, Nathan D., Bang, Matthew, Block, Robert C., Peterson, Amy L.H., Karalis, Dean G.
Zdroj: In The American Journal of Cardiology 1 August 2021 152:57-62
Databáze: ScienceDirect